Interactions of human immunodeficiency virus type 1 transactivator of transcription protein with signal transduction pathways

被引:3
作者
Garza, HH
Carr, DJJ
机构
[1] LOUISIANA STATE UNIV,MED CTR,DEPT IMMUNOL MICROBIOL,NEW ORLEANS,LA 70112
[2] LOUISIANA STATE UNIV,MED CTR,DEPT PARASITOL,NEW ORLEANS,LA 70112
[3] LOUISIANA STATE UNIV,MED CTR,CTR NEUROSCI,NEW ORLEANS,LA 70112
来源
ADVANCES IN NEUROIMMUNOLOGY | 1995年 / 5卷 / 03期
关键词
D O I
10.1016/0960-5428(95)00014-S
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The current state of knowledge investigating Tat interactions with signal transduction pathways is still in its infancy but has made significant progress toward understanding HIV pathology. This area is of great interest because Tat is among a small group of newly discovered RNA-based regulators of transcription. What is more important, however, are the implications of understanding these interactions concerning HIV-infected individuals. With the failure to develop effective HIV vaccines after years of development, it is becoming more feasible to conjecture therapies that target Tat as a means to keep HIV in its quiescent state rather than to eliminate the virus. In either case, the intense study of Tat and signal transduction pathways promises to provide a wealth of information about transcriptional control as well as the regulation of immune cell activation. © 1995.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 27 条
[1]   ARGININE-MEDIATED RNA RECOGNITION - THE ARGININE FORK [J].
CALNAN, BJ ;
TIDOR, B ;
BIANCALANA, S ;
HUDSON, D ;
FRANKEL, AD .
SCIENCE, 1991, 252 (5009) :1167-1171
[2]   ANALYSIS OF ARGININE-RICH PEPTIDES FROM THE HIV TAT PROTEIN REVEALS UNUSUAL FEATURES OF RNA PROTEIN RECOGNITION [J].
CALNAN, BJ ;
BIANCALANA, S ;
HUDSON, D ;
FRANKEL, AD .
GENES & DEVELOPMENT, 1991, 5 (02) :201-210
[3]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT ACTIVITY BY COEXPRESSION OF HETEROLOGOUS TRANS ACTIVATORS [J].
CARROLL, R ;
PETERLIN, BM ;
DERSE, D .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2000-2007
[4]   MECHANISM OF ACTION OF REGULATORY PROTEINS ENCODED BY COMPLEX RETROVIRUSES [J].
CULLEN, BR .
MICROBIOLOGICAL REVIEWS, 1992, 56 (03) :375-394
[5]  
DANG CV, 1989, J BIOL CHEM, V264, P18019
[6]   THE TRANSACTIVATOR GENE OF THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III IS REQUIRED FOR REPLICATION [J].
DAYTON, AI ;
SODROSKI, JG ;
ROSEN, CA ;
GOH, WC ;
HASELTINE, WA .
CELL, 1986, 44 (06) :941-947
[7]   THE TUMOR-SUPPRESSOR PROTEIN P53 STRONGLY ALTERS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION [J].
DUAN, LX ;
OZAKI, I ;
OAKES, JW ;
TAYLOR, JP ;
KHALILI, K ;
POMERANTZ, RJ .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4302-4313
[8]   THE HUMAN IMMUNODEFICIENCY VIRUS - INFECTIVITY AND MECHANISMS OF PATHOGENESIS [J].
FAUCI, AS .
SCIENCE, 1988, 239 (4840) :617-622
[9]   THE ROLE OF TAT IN THE HUMAN-IMMUNODEFICIENCY-VIRUS LIFE-CYCLE INDICATES A PRIMARY EFFECT ON TRANSCRIPTIONAL ELONGATION [J].
FEINBERG, MB ;
BALTIMORE, D ;
FRANKEL, AD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :4045-4049
[10]   FUNCTIONAL DOMAINS REQUIRED FOR TAT-INDUCED TRANSCRIPTIONAL ACTIVATION OF THE HIV-1 LONG TERMINAL REPEAT [J].
GARCIA, JA ;
HARRICH, D ;
PEARSON, L ;
MITSUYASU, R ;
GAYNOR, RB .
EMBO JOURNAL, 1988, 7 (10) :3143-3147